Cristiana Abbafati
ORCID 0000-0003-2811-6251
Department of Juridical and Economics Studies
Sapienza University of Rome
00185 Roma (Italia), tel.+39 06 49910696, fax. +39 06 4453870
E-mail: cristiana.abbafati@uniroma1.it
OTHER POSITIONS
Scientific Committee, Global Burden of Disease Study, Institute of Health Metrics and Evaluation, University of Washington, Seattle
Member of Global Burden of Disease expert group, Institute of Health Metrics and Evaluation, University of Washington, Seattle
Member of Global Burden of Disease health financing expert group, Institute of Health Metrics and Evaluation, University of Washington, Seattle
Deputy Director of Global Burden of Disease Italian Initiative
Member of European Cooperation in Science and Technology, Cost Action, European Burden of Disease
Rapporteur and Review Panel Member for Cost Action 2025-2027 Health Sciences
Member of the Academic board of the PhD program in Political Studies, Sapienza University
Scientific Committee, International Health Economics Association, 2023 and 2025 Congress
Member of Health Science Sub-Panel for the Periodic Assessment of Research, Development, Artistic and other Creative Activities, Slovak Republic
Task leader "Conceptualizing and retrieving key indicators from Spoke 1 to 10", Spoke 1, Age-it project
RESEARCH FIELDS
Intergenerational transmission of health, chronic diseases, intermediate risk factors for chronic diseases, health system, health system sustainability, health expenditures, and health financing, health services performance, social capital and health, burden of disease, economic growth, inequality and health, educational, skill mismatch and health, health technology assessment, economic and social determinants of T2DM and Alzheimer and other dementia, economic burden of diabetes, economic of aging, universal health coverage, enviromental pollution and health
EDITORIAL BOARD
SobreMéxico Temas de Economia, Frontiers in Public Health, Health Economics Section, Frontiers in Health Services, Health Policy and Management Section, Plos On, Studi Politici
REFEREE
Applied Health Economics and Health Policy, BMC Public Health, BMC Health Services Research, Central European Journal of Public Health, Environmental Research, Epidemiology and Infection, European Journal of Public Health, Frontiers in Health Economics, Frontiers in Health Policy and Management, Health Economics, Health Economics Policy and Law, Health Services Research, Journal of Medical Internet Research, Environment, Development and Sustainability, Environmental Impact Assessment Review, Journal of Public Health, Journal of Health Economics and Outcomes Research, JMIR Public Health and Surveillance, PLOS One, Preventive Medicine Reports, Public Health, Sobre Mexico, Studi Politici, The Lancet Global Health, The Lancet Infection Diseases, The Lancet Regional Health, Social Sceince and Medicine, Scientific Reports, Health Policy
EDUCATION
PhD in Economic Analysis of Social Phenomena, Sapienza University of Rome
MSc in Applied Econometrics, “E. Vanoni” School of Public Administration, Rome
MSc in Health Economics, City University of London
BS in Economics and political science, 110/110 summa cum laude, Sapienza University of Rome
TEACHING
Health Economics, Development Economics, Labor Economics
PUBBLICATIONS > 60 n. citations > 100,000 h-index 56 (source Scopus)
https://www.scopus.com/authid/detail.uri?authorId=54917122400
https://www.researchgate.net/profile/Abbafati-Cristiana
WORK EXPERIENCE
02/03/2006 – CURRENT Rome, Italy
HEALTH ECONOMIST, SAPIENZA UNIVERSITY OF ROME
01/02/1998 – 19/02/2006 Rome, Italy
ECONOMIST, INAPP, NATIONAL INSTITUTE FOR PUCLIC POLICIES ANALYSYS
EDUCATION AND TRAINING
2019 Washington, United States
Advance Course, Global Burden of Disease (GBD), Institute of Health Metrics and Evaluation, University of Washington
2013 Rome, Italy
MSC IN APPLIED ECONOMETRICS “E. Vanoni” School of Public Administration
2009 London, United Kingdom
MSC IN HEALTH ECONOMICS City University of London
2001 Rome
PHD IN ECONOMIC ANALYSIS OF SOCIAL PHENOMENA Sapienza University of Rome
1996 Rome, Italy
BS ECONOMICS AND POLITICAL SCIENCE Sapienza University of Rome
LANGUAGE SKILLS
production interaction
Levels: A1 and A2: Basic user; B1 and B2: Independent user; C1 and C2: Proficient user
DIGITAL SKILLS
Microsoft Office Microsoft Word Microsoft Excel Microsoft Powerpoint EndNOte zoom google drive STATA
ADDITIONAL INFORMATION
NETWORKS AND MEMBERSHIPS
Member of Working Group, European Cooperation in Science and Technology, Cost Action European Burden of Disease CA18218, Start Date: 28 October 2019, End Date: 27 April 2024
Member of Scientific Council, Global Burden of Disease Study, Institute of health Metrics and Evaluation, University of Washington, Seattle (USA)
Member of GDB (Global Burden of Disease) experts’ group, Institute of Health Metrics and Evaluation, University of Washington, Seattle (USA)
Member of GBD health financing expert group, Institute of Health Metrics and Evaluation, University of Washington, Seattle (USA)
Deputy Director of GBD Italian Initiative
Collaborator with CREA (Center of Applied Research on Health)
Member of IHEA (International Health Economic Association)
Member of Scientific Committee, IHEA, 2023 Congress
Member of AIES (Health Economics Italian Association)
Member of SIEDS (Italian Society of Economics, Statistics and Demography)
Member of the Academic Board of the PhD program in Political Studies, Sapienza University
Task leader "Conceptualizing and retrieving key indicators from Spoke 1 to 10", Spoke 1, Partenariato Esteso Age-it project “Ageing well in an aging society”
Member of Health Science Sub-Panel for the 2022 Periodic Assessment of Research, Development, Artistic and other Creative Activities, Slovak Republic.
CONFERENCES AND SEMINARS (recent years)
2023 November:, Measuring performance on the Healthcare Access and Quality Index for 21 Italian regions, 20 November, Trieste, Italy
2023 November: The national health system today. How it will be its future?, Congresso Nazionale Associazione Medici Diabetologi, AMD, 05-08 Florance, Italy
2023 September: Data needs and innovation, First kick off Meeting for Age-it, PNRR project, University of Florance
2022 March: Keynes l’Eretico. Incontro con on. Giorgio La Malfa. Sapienza University of Rome
2021, May: Il Servizio sanitario nazionale e il Piano Nazionale Ripresa e resilienza. Incontro con on. Rosy Bindi. Sapienza University of Rome
2020, February: Cost Action, European Burden of Disease, Development and growth of the Italian Global Burden of Disease Initiative, National Food Institute (DTU), Lyngby Copenhagen, Denmark
2020, February: Cost Action European Burden of Disease, GBD data for health care planning. The importance to account for disproportions in prevalence and disability-adjusted life-years, National Food Institute (DTU), Lyngby Copenhagen, Denmark
2020, February: Cost Action European Burden of Disease, Disability weights for the calculation of DALYs: a new approach to evaluate the efficacy of countries’ policies, National Food Institute (DTU), Lyngby Copenhagen, Denmark
2020, January: Sapienza University of Rome Diabetes: AMD dataset and burden of disease
2018, December: Sapienza University, GBD: a crucial resource for health planning
2018, April: ISS, National Institute of Health, GBD estimates for Italy: analyzing the impact of the economic crisis on health indicators, Rome
2018, January: Global burden of Disease. The Italian initiative, Rome
2017, November: ISS, National Institute of Health, Welfare and health policies: using evidence from the Global Burden of Disease Rome
2014, July: 10th World Congress iHEA (International Health Economics Association), Social Capital and health in Mexico: a probit estimation, Trinity College, Dublin
2014, May: SOMEDE (Sociedad Mexicana de Demografia), Social Capital and health in Mexico: a
probit estimation Universidad Iberoamericana,Mexico City
2013, October: XXI Annual Meeting of the LACEA/IADB/WB/UNDP, Research Network on
Inequality and Poverty (NIP) of World Bank, Social Capital and health in Mexico: a probit estimation Universidad Iberomericana, Mexico City
2013, May: Relacion de Capital Social y los indicadores de salud y los niveles de seguridad alimentaria en Mexico in Analis sobre la relacion Capital Social y desarollo en America Latina, Universidad Iberoamericana, Mexico City
2012, June: COLMEX, Colegio de Mexico, Mexico City, Social Capital and health in Mexico
2012, March: UPAEP University of Puebla (Mexico), Public policies in health sectors
2011, October: AIES (Italian Health Economics Association), Standard Costs in Health Care
2010, November: AIES (Italian Health Economics Association), Social capital and public health service quality
2010, October: Parental influence on children’s unhealthy lifestyle activities in United Kingdom, City University of London, London, UK
PROJECTS (recent years)
2022-2024 Data needs and innovation. Conceptualizing and retrieving key indicators from WP
1-4, Spoke 1, Progetto Age-it, partenariati estesi, PNRR
2021-2022 I medici di medicina generale nel rilancio del servizio sanitario nazionale, Sapienza Università di Roma
2020-2021 Sostenibilità del sistema sanitario, disuguaglianze socioeconomiche e autonomia
regionale: l'esperienza della pandemia COVID 19, Sapienza Università di Roma
2019-2020 Finanza etica e microcredito: inclusione sociale e finanziaria, Sapienza Università di Roma
2017-2018 Le politiche economiche per la crisi economico-finanziaria e l'impatto sulla natura delle fonti del diritto, Sapienza Università di Roma
2017-2018 Economic and social implications of the burden of disease: DALYs and YLDs in
Italy, Sapienza Università di Roma
2016-2017 Territorial dynamic and wellness with Isidro Soloaga, Universidad IberoAmericana, Città del Messico
2015-2016 Federalismo, efficacia ed efficienza dei servizi sanitari, Università Tor Vergata
2012-2014 Social Capital and health for Mexicans and Italian, with Edwin Van Garmer, Colegio de Mexico, Città del Messico, Messico
2012-2013 Qualità dei servizi sanitari e ineguale distribuzione del Reddito, Sapienza Università di Roma
2011-2012 Social Capital and health for Mexicans with Isidro Soloaga and Edwin Van Garmer, Colegio de Mexico, Città del Mexico, Messico
2010-2011 Una riconsiderazione dei costi in Sanità, Sapienza Università di Roma
TEACHING EXPERIENCE
a.a.2023-2024: Labour Economics and Applied Economics, Sapienza University of Rome
a.a.2022-2023: Labour Economics, Applied Economics and Institutional Economics and Development Theory, Sapienza University of Rome
a.a.2020-2021: Economics of Health Services, Sapienza University of Rome
a.a.2020-2021: Institutional Economics and Development Theory, Economics and Institutional Economics, Sapienza University of Rome, degree of Law and Political Science
a.a.2019-2020: Institutional Economics and Development Theory, Economics and Institutional Economics, Sapienza University of Rome, degree of Law and Political Science
a.a.2018-2019: Institutional Economics and Development Theory and Microeconomics, Sapienza University of Rome, degree of Law and Political Science
a.a.2017-2018: Institutional Economics and Development Theory and Microeconomics, Sapienza University of Rome, degree of Law and Political Science
a.a. 2016-2017: Institutional Economics and Development Theory, Sapienza University of
Rome, degree of Law
a.a. 2015-2016: Economics of Tourism, “Unitelma Sapienza”, Rome
a.a. 2015-2016: Institutional Economics and Development Theory, Sapienza University of
Rome, degree of Law
a.a. 2014-2015: Institutional Economics and Development Theory, Sapienza University of
Rome, degree of Law
a.a. 2012-2014: Economics, Sapienza University of Rome, degree of Economics of Tourism
a.a. 2011-2012: Microeconomics, Sapienza University of Rome, degree of Economics of Tourism
a.a. 2006-2011: Economics, Sapienza University of Rome, degree of International, Political Science, Pomezia campus
a.a. 2006-2007: Economics, Sapienza University of Rome, degree of Communication
a.a. 2006-2007: Economics, LUISS Guido Carli University, degree of Law
RESEARCH FIELDS
Intergenerational transmission of healthy; lifestyle; chronic diseases; intermediate risk factors for chronic diseases; Mechanisms of division of the National Health Fund; standardization for health care costs; Quality or performance of public health services; Universal Health Coverage; Social capital and health; Burden of disease: DALYs, YYLs, YLDs; Health Technology Assessment; Health, Economic Growth and Inequality; Health expenditures and health financing; Work and health, Educational mismatch and Skill mismatch and health, Aging.
EDITORIAL BOARD
Sobre México Revista de Economía. Temas de Economia, Frontiers in Public Health, Health Economics Section
Frontiers in Health Services, Health Policy and Management Section, Plos On, Studi Politici, Health Metrics
REFEREE
Applied Health Economics and Health Policy, BMC Public Health, BMC Health Services Research, Central European Journal of Public Health, Environmental Research, Environmental Impact Assessment, Epidemiology and Infection, European Journal of Public Health, Frontiers in Health Economics, Frontiers in Health Policy and Management, Health Economics, Health Economics Policy and Law, Health Policy, Health Services Research, Journal of Medical Internet Research, Environment, Development and Sustainability, Journal of Public Health, Journal of Health Economics and Outcomes Research, JMIR Public Health and Surveillance, PLOS One, Preventive Medicine Reports, Sobre Mexico, Social Science and Medicine, Studi Politici, Scientific Report, Sustainable Development, The Lancet Global Health, The Lancet Infection Diseases, The Lancet Regional Health.
PUBLICATIONS (recent years)
Scopus
84,374 Citations
45 H-index
2024
1. Measures of type 2 diabetes burden in Italy assessed using the AMD dataset over a twelve year span across the Great Recession. Sci Rep 14, 4901 (2024). https://doi.org/10.1038/s41598-024-54989-8
2023
1. Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026, Lancet Glob Health. 2023 Jan, doi: 10.1016/S2214-109X(23)00007-4.
2. Time-Trends in Air Pollution Impact on Health in Italy, 1990–2019: An Analysis from the Global Burden of Disease Study 2019 , International Journal of Public Health, 2023, Vol. 68, doi: 10.3389/ijph.2023.1605959
2022
3. COVID-19 Vaccination Coverage in Italy: How Many Hospitalizations and Related Costs Could Have Been Saved If We Were All Vaccinated? Zamagni G, Armocida B, Abbafati C, Ronfani L. and Monasta L., 2022, Front. Public Health, doi.org/ 10.3389/fpubh.2022.825416
4. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality,2020–21, The Lancet, March 10, 2022, doi.org/10.1016/S0140-6736(21)02796-3
5. Diabetes mortality and trends betweeen 25 years of age: an analysis of the Global Burden of Disease Study 2019, The Lancet Diabetes & Endocrinology, March 2022, doi.org/10.1016/S2213-8587(21)00349-1
6. Estimates, trends, and drivers of the global burden of type 2 diabetes attributable to PM2·5 air pollution, 1990–2019: an analysis of data from the Global Burden of Disease Study 2019, The Lancet Planetary Health, July 2022, doi.org/10.1016/S2542-5196(22)00122-X
7. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021, The Lancet, April 2022, doi.org/10.1016/S0140-6736(22)00172-6
8. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis, The Lancet, July 2022, doi.org/10.1016/S0140-6736(22)00484-6
9. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis the Global Burden of Disease Study 2020, July 2022, doi.org/10.1016/S0140-6736(22)00847-9
10. Assessing permance of the Healthcare Access and Quality Index, overall and by select age groups, 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019. Lancet Global Health. 2022 October 6, doi: 10.1016/S2214-109X(22)00429-6
11. Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021. JAMA, October 10, 2022. doi:10.1001/jama.2022.18931
12. Il personale sanitario nel rilancio del SSN, tra krísis economica, pandemica e PNRR, contributo in volume Lavoro, Occupazione, Diseguaglianze, a cura di Nicola Boccella e Cristiana Abbafati, Led Scienze Sociali, ISBN 9788879169950
2021
13. An ANN experiment on the Indian economy: can the change in pollution generate an increase or decrease in GDP acceleration? with Mele M., Nieddu L., Quarto A., Environmental Science and Pollution Research, March 2021, doi.org/10.1007/s11356-021-13182-4.
14. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019, The Lancet, May 27, 2021 doi :https://doi.org/10.1016/S0140-6736(21)01169-7
2020
15. Viewpoint Collaborators. Five insights from the Global Burden of Disease Study 2019. Lancet. 2020 Oct 17;396(10258):1135-1159. doi: 10.1016/S0140-6736(20)31404-5. PMID: 33069324; PMCID: PMC7116361.
16. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis the Global Burden of Disease Study 2019, The Lancet, October 17, 2020, doi: 10.1016/S0140-6736(20)30925-9
17. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis the Global Burden of Disease Study 2019,The Lancet, October 17, 2020, doi: 10.1016/S0140-6736(20)30752-2
18. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990–2019: a systematic analysis the Global Burden of Disease Study 2019. The Lancet. 27 August 2020. doi:10.1016/S0140-6736(20)30750-9
19. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance health: progress towards Sustainable Development Goal 3, The Lancet, April 23, 2020, doi: 10.1016/S0140-6736(20)30608-5
20. Global and regional burden of disease and injury in 2016 arising from occupational exposures: a systematic analysis the Global Burden of Disease Study 2016, Occupational and Environmental Medicine, February 2020; 77:133-141, doi: 10.1136/oemed-2019-106008
21. Global and regional burden of chronic respiratory disease in 2016 arising from non-infectious airborne occupational exposures: a systematic analysis the Global Burden of Disease Study 2016, Occupational and Environmental Medicine; February 2020; 77:142-150, doi: 10.1136/oemed-2019-106013
2019
22. Italy's health permance, 1990–2017: findings from the Global Burden of Disease Study 2017, GBD 2017 Italy Collaborators, Lancet Public Health, November 20, 2019 doi.10.1016/S2468-2667(19)30189-6
23. Crisi economica e politiche sanitarie: la salute degli italiani secondo i dati del Global Burden of Disease, in Crisi economico-finanziaria, legge di bilancio e fonti del diritto, a cura di Nicola Boccella, Ed. Nuova Cultura, Dicembre 2019
24. Past, present, and future of global health financing: a review of development assistance, government, out-of-pocket, and other private spending on health 195 countries, 1995-2050, Lancet April 2019 393(10187):2233-2260, doi:10.1016/S0140-6736(19)30841-4
2018
25. Global, regional and national incidence, prevalence and years lived with disability 354 disease and injuries 195 countries and territories, 1990-2017 :a systematic analysis the Global Burden of Disease Study 2017, Lancet, 2018 Nov10;392(10159):1789-1858.doi: 10.1016/S0140-6736(18)32279-7;
26. Global, regional, and national age-sex-specific mortality 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis the Global Burden of Disease Study 2017, Lancet 2018 Nov 10;392(10159):1736-1788. doi: 10.1016/S0140-6736(18)32203-7
27. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis the Global Burden of Disease Study 2017, Lancet 2018 Nov 10;392(10159):1684-1735. doi: 10.1016/S0140-6736(18)31891-9
28. Global, regional, and national comparative risk assessment of 84 behavioral, environmental and occupational, and metabolic risks or clusters of risks 195 countries and territories, 1990-2017: a systematic analysis the Global Burden of Disease Study 2017, Lancet. 2018 Nov 10;392(10159):1923-1994. doi: 10.1016/S0140-6736(18)32225-6
29. Global, regional, and national disability-adjusted life-years (DALYs) 359 diseases and injuries and healthy life expectancy (HALE) 195 countries and territories, 1990-2017: a systematic analysis the Global Burden of Disease Study 2017, Lancet. 2018 Nov 10;392(10159):1859-1922. doi: 10.1016/S0140-6736(18)32335-3
30. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals 195 countries and territories: a systematic analysis the Global Burden of Disease Study 2017, Lancet. 2018 Nov 10;392(10159):2091-2138. doi: 10.1016/S0140-6736(18)32281-5
31. Alcohol use and burden 195 countries and territories, 1990-2016: a systematic analysis the Global Burden of Disease Study 2016, Lancet. 2018 Sep 22;392(10152):1015-1035. doi: 10.1016/S0140-6736(18)31310-2.
32. Spending on health and HIV/AIDS: domestic health spending and development assistance in 188 countries, 1995–2015. Lancet. 2018 May 5;391(10132):1799-1829. doi: 10.1016/S0140-6736(18)30698-6.
33. Trends in future health financing and coverage: future health spending and universal health coverage in 188 countries, 2016–40. Lancet. 2018 May 5;391(10132):1783-1798. doi: 10.1016/S0140-6736(18)30697-4.
34. HTA Report. Interstitial cystitis/BPS: the treatment with hyaluronic acid, C.R.E.A. Sanità, March, 2018.
35. Crescita economica, disuguaglianze e peso della malattia, Sapienza University Press, April 2018, ISBN978-88-9377-053-8
2017
36. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1345-1422. doi: 10.1016/S0140-6736(17)32366-8
37. Global, regional, and national disability-adjusted life-years (DALYs) 333 diseases and injuries and healthy life expectancy (HALE) 195 countries and territories, 1990-2016: a systematic analysis the Global Burden of Disease Study 2016. Lancet 2017 Sep 16;390(10100):1260-1344. doi: 10.1016/S0140-6736(17)32130-X.
38. Global, regional, and national incidence, prevalence, and years lived with disability 328 diseases and injuries 195 countries, 1990-2016: a systematic analysis the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1211-1259. doi: 10.1016/S0140-6736(17)32154-2.
39. Global, regional, and national age-sex specific mortality 264 causes of death, 1980-2016: a systematic analysis the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1151-1210. doi: 10.1016/S0140-6736(17)32152-9.
40. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis the Global Burden of Disease Study 2016. Lancet. 2017 Sep 16;390(10100):1084-1150. doi: 10.1016/S0140-6736(17)31833-0.
41. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. Lancet 2017 Sep 16;390(10100):1423-1459. doi: 10.1016/S0140-6736(17)32336-X.
42. Burden of obesity in the Eastern Mediterranean Region: findings from the Global Burden of Disease 2015 study. International Journal of Public Health. 2017 Aug 3. doi: 10.1007/s00038-017-1002-5.
43. Health Effects of Overweight and Obesity in 195 Countries over 25 Years. New England of Journal Medicine, 2017 Jul 6;377(1):13-27. doi: 10.1056/NEJMoa1614362.
44. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015. Lancet. 2017 Jul 15;390(10091):231-266. doi: 10.1016/S0140-6736(17)30818-8.
45. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990-2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017 May 13;389(10082):1885-1906. doi: 10.1016/S0140-6736(17)30819-X.
46. Mortality and DALYS caused by risk factors, Chapter 5b, 13th Health Report-The change of Italian healthcare system between transition and leeway CREA SANITA’, 2017, ISBN 9788894123623
47. Inequality and out of pocket, Sole 24 Sanità, April 2017, ISSN 2499-6599
2016
48. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis the Global Burden of Disease Study 2015. Lancet 2016 Oct 8;388(10053):1659-1724. doi: 10.1016/S0140-6736(16)31679-8.
49. Global, regional, and national disability-adjusted life-years (DALYs) 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1603-1658. doi: 10.1016/S0140-6736(16)31460-X.
50. Global, regional, and national incidence, prevalence, and years lived with disability 310 diseases and injuries, 1990-2015: a systematic analysis the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1545-1602. doi: 10.1016/S0140-6736(16)31678-6.
51. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality 249 causes of death, 1980-2015: a systematic analysis the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1459-1544. doi: 10.1016/S0140-6736(16)31012-1.
52. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. Lancet. 2016 Oct 8;388(10053):1813-1850. doi: 10.1016/S0140-6736(16)31467-2.
53. The social demographic context: years of good health lost and the burden of disease”, Chapter 1, 12th Health Report-Health between institutional and social balances, CREA SANITA’, 2016. ISBN 9788894123616
54. In Europe we all live longer but worse and with more disability,Sole 24 Sanità, May 2016, ISSN 2499-6599
2015
55. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis the Global Burden of Disease Study 2013. Lancet. 2015 Dec 5;386(10010):2287-323. doi: 10.1016/S0140-6736(15)00128-2.
56. Global, regional, and national incidence, prevalence, and years lived with disability 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis the Global Burden of Disease Study 2013. Lancet. 2015 Aug 22;386(9995):743-800. doi: 10.1016/S0140-6736(15)60692-4.
2014
57. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis the Global Burden of Disease Study 2013. Lancet. 2014 Aug 30;384(9945):766-81. doi: 10.1016/S0140-6736(14)60460-8
2011
59. Parents and Children: lifestyles and occurrence of chronic diseases, Tendenze Nuove, Materiali di lavoro su sanità e salute, n.3, 2011.
60. Social Capital and quality of health services (with F. Spandonaro), Mecosan, n.78,2011;
61. Standard Costs in Health Care (with F. Spandonaro), Politiche Sanitarie, vol.12, n.2, 2011;
62. The Influence of Lifestyles on Chronic Diseases: intermediate risk factors, Care n.2,
Rome, 29/0/2024